Chronic Hepatitis B
- 2 August 1990
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (5), 337-339
- https://doi.org/10.1056/nejm199008023230510
Abstract
Chronic hepatitis B is said to affect at least 5 percent of the world's population and to be the chief cause of cirrhosis and hepatocellular carcinoma.1 The World Health Organization lists hepatitis B as the ninth major cause of death worldwide, close behind chronic pulmonary disease and well ahead of the acquired immunodeficiency syndrome. These estimates suggest that chronic hepatitis B virus (HBV) infection is the most important chronic viral infection affecting humans.The portrayal of chronic hepatitis B as a major health risk must strike most U.S. physicians as somewhat forced or exaggerated. In this country and other developed . . .Keywords
This publication has 8 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive FactorsHepatology, 1989
- Seroepidemiology of Hepatitis B virus infection in the United States 1976 to 1980The American Journal of Medicine, 1989
- MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1989
- Compact organization of the hepatitis B virus genomeHepatology, 1989
- Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.Proceedings of the National Academy of Sciences, 1989
- Chronic type B hepatitis and the “healthy” Hbsag carrier stateHepatology, 1987
- Long-term follow-up study of asymptomatic hbsag-positive voluntary blood donors in austria: A clinical and histologic evaluation of 242 casesHepatology, 1987